Effects of ivabradine on plaque burden, morphology and composition in patients with clinically indicated coronary angiography. A randomised double-blind placebo-controlled international multicentre study.
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Registrational; Therapeutic Use
- Acronyms MODIFY
- Sponsors IRIS
- 09 May 2015 Status changed from recruiting to discontinued as per European Clinical Trials Database record.
- 07 May 2013 New trial record